Ozone Pharmaceuticals CMD launches his latest book 13 Prescriptions for Success in Life

New Delhi: SC Sehgal, Chairman and Managing Director of Ozone Pharmaceuticals, unveiled his much-awaited book 13 Prescriptions for Success in Life at Le Meridien, New Delhi, on Thursday. Published by Notion Press, the book was officially released on August 27 across major e-commerce platforms, including Notionpress.com.

Drawing upon decades of entrepreneurial leadership and personal reflection, Sehgal distilled his philosophy that “to succeed you need strength, but to sustain success you need humility.” The work, positioned as much a guide for boardrooms as for life, encapsulates learnings gathered through experience, setbacks, and growth.

The launch was graced by Dr. Kiran Bedi, India’s first woman IPS officer, who attended as Chief Guest. Lauding the book, she said, “The outlook for any enterprise must be growth with service, not status. Power is best reflected in the way it serves people, not in the position it commands. This book is filled with quotable quotes that, when reread daily, offer new perspective. I hope Ozone grows by leaps and bounds, becomes synonymous with Make in India and Make for the World, and continues to generate employment, service, and pride for the nation.”

Sehgal described the work as “not prescriptions from a pedestal, but experiential learning.” He emphasized that the book is a humble attempt to provide readers with a compass to grow with discipline, service, and purpose.

From a modest beginning, Sehgal has steered Ozone Pharmaceuticals into one of India’s most respected pharma companies. With revenues poised to reach Rs 1,000 crore, Ozone today symbolizes the Make in India dream—Indian in heart, global in vision. That same ethos informs the book: success means responsibility to create lasting impact and legacy.

Related Posts

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

Lundbeck, a biopharmaceutical company focusing exclusively on brain health, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to asedebart (Lu AG13909), Lundbeck’s novel…

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Fujifilm India, a leader in advanced diagnostic imaging and healthcare technology, has installed and commissioned the Fujifilm Echelon Smart MRI at Jansons Health in Erode. The installation expands access to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure

AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure